Profiles

Keywords
Last Name
Institution

Connection

Search Results to David Lee Williams

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Williams, David

PropertyValue
overview My Scopus ID is 55574201569. My NIH COMMONS name is DLWILLI. Research Areas: Schistosomiasis, redox biology, drug development. My Faculty Profile at Rush University Medical Center: https://www.rushu.rush.edu/faculty/david-l-williams-phd My Laboratory: https://www.rushu.rush.edu/research/departmental-research/microbial-pathogens-and-immunity-research/laboratory-david-l-williams-phd My NCBI Bibliography: https://www.ncbi.nlm.nih.gov/pubmed/?term=David+L+Williams My Scopus: https://www.scopus.com/authid/detail.uri?authorId=55574201569

One or more keywords matched the following items that are connected to Williams, David

Item TypeName
Concept Schistosomiasis mansoni
Concept Schistosomiasis haematobia
Concept Schistosomiasis
Academic Article Murine immune responses to a novel schistosome egg antigen, SmEP25.
Academic Article Profiling Schistosoma mansoni development using serial analysis of gene expression (SAGE).
Academic Article Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target.
Academic Article Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade.
Academic Article Identification of oxadiazoles as new drug leads for the control of schistosomiasis.
Academic Article Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.
Academic Article Biomphalaria glabrata peroxiredoxin: effect of schistosoma mansoni infection on differential gene regulation.
Academic Article The genome of the blood fluke Schistosoma mansoni.
Academic Article Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.
Academic Article The redox biology of schistosome parasites and applications for drug development.
Academic Article Synthesis and biological evaluation of 1,4-naphthoquinones and quinoline-5,8-diones as antimalarial and schistosomicidal agents.
Academic Article Synthesis and evaluation of 1,4-naphthoquinone ether derivatives as SmTGR inhibitors and new anti-schistosomal drugs.
Academic Article High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis.
Academic Article The Schistosoma mansoni Cytochrome P450 (CYP3050A1) Is Essential for Worm Survival and Egg Development.
Academic Article Molecular and enzymatic characterisation of Schistosoma mansoni thioredoxin.
Academic Article Differential production in vitro of antigen specific IgG1, IgG3 and IgA: a study in Schistosoma haematobium infected individuals.
Academic Article Schistosome infection stimulates host CD4(+) T helper cell and B-cell responses against a novel egg antigen, thioredoxin peroxidase.
Academic Article Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as "Doorstop" for NADPH Entry.
Academic Article Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.

Search Criteria
  • Schistosomiasis